Trial Details
Not RecruitingBasic Information
| Clinical ID | c5098 |
|---|---|
| Identifier | EUCTR2015-001942-28-CZ |
| Trial Title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Ulcerative colitis MedDRA version: 19.0.Level: LLT.Classification code 10045365.Term: Ulcerative colitis.System Organ Class: 100000004856.;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Code: APD334Pharmaceutical Form: Capsule, hardINN or Proposed INN: Not yet availableCurrent Sponsor code: APD334Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 1-Pharmaceutical form |
Participant Information
| Sponsor | Arena Pharmaceuticals, Inc. |
|---|---|
| City | NULL |
| Country/Region | United States;Spain;Ukraine;Lithuania;Austria;Israel;United Kingdom;France;Czech Republic;Hungary;Canada;Poland;Belgium;Romania;Australia;Bulgaria;Latvia;Germany;New Zealand |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |